Pure Global

A COMPARISON OF TRANSDERMAL DICLOFENAC AND ORAL COMBINATION OF PARACETAMOL AND IBUPROFEN IN POSTOPERATIVE PAIN MANAGEMENT FOLLOWING SURGICAL EXTRACTION OF MANDIBULAR THIRD MOLAR- A RANDOMISD CONTROLLED TRIALS. - Trial NCT06146491

Access comprehensive clinical trial information for NCT06146491 through Pure Global AI's free database. This Phase 4 trial is sponsored by B.P. Koirala Institute of Health Sciences and is currently Recruiting. The study focuses on Pain, Postoperative. Target enrollment is 108 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06146491
Phase 4
Recruiting
drug
Trial Details
ClinicalTrials.gov โ€ข NCT06146491
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A COMPARISON OF TRANSDERMAL DICLOFENAC AND ORAL COMBINATION OF PARACETAMOL AND IBUPROFEN IN POSTOPERATIVE PAIN MANAGEMENT FOLLOWING SURGICAL EXTRACTION OF MANDIBULAR THIRD MOLAR- A RANDOMISD CONTROLLED TRIALS.
A COMPARISON OF ANALGESIC EFFICACY OF TRANSDERMAL DICLOFENAC AND ORAL COMBINATION OF PARACETAMOL AND IBUPROFEN IN POSTOPERATIVE PAIN MANAGEMENT FOLLOWING SURGICAL EXTRACTION OF MANDIBULAR THIRD MOLAR

Study Focus

Pain, Postoperative

Oral tablet and transdermal patch

Interventional

drug

Sponsor & Location

B.P. Koirala Institute of Health Sciences

Dharฤn Bฤzฤr, Nepal

Timeline & Enrollment

Phase 4

Aug 10, 2023

Jan 15, 2024

108 participants

Primary Outcome

To compare the analgesic effectiveness of diclofenac trans dermal patch (200mg) and oral combination of paracetamol (500mg) and ibuprofen (400mg) following surgical removal of mandibular third molar.

Summary

This is comparative interventional study, will be conducted in patient indicated for surgical
 extraction of mandibular third molar at the Department of Oral and Maxillofacial surgery,
 College of Dental Surgery, BPKIHS, Nepal. Verbal and written will be taken . Participants
 meeting inclusion criteria will be included in the study and will be divided in to two
 groups, group A (Oral combination of paracetamol-500mg and ibuprofen -400mg) and group B (
 Transdermal diclofenac patch-200mg) using computer generated randamization. Extraction will
 be carried out using standard protocol. Aformention drugs will given to participants
 accordingly for management of post operative pain.Tramadol will be given to each patient as
 rescue analgesics and allowed to have if pain score exceeds 7.post operative instruction will
 be given carefully. Rescue phone number will be provided in case of emergency. Telephonic
 interview will be performed at 12, 24 and 72 hours post operatively and pain score using
 numeric rating scale will be recorded.Any adverse effects of drugs will be recorded. The data
 collected will be entered in Microsoft excel sheet. It will then be transferred into SPSS
 (Statistical Package for Social Sciences) for statistical analysis.

ICD-10 Classifications

During surgical operation
During surgical operation
During surgical operation
Pain, unspecified
Postoperative intestinal obstruction

Data Source

ClinicalTrials.gov

NCT06146491

Non-Device Trial